This personalization tool helps providers understand individual differences in how semaglutide may influence satiety, glucose metabolism, and lipid regulation at the genetic level
The February 2026 TRIUMPH-4 readout showed 32.3 kg weight loss and 75.8% knee pain reduction at the 12 mg dose at 68 weeks
Sleep disruption can influence how the body handles stress and digestive signals
The additional action on GCG receptors leads to delayed gastric emptying, further promoting satiety
The newest kid on the block The ATTAIN-2 trial was conducted across 10 countries and involved more than 1,600 people who were obese or overweight with type 2 diabetes
These include early pharmacokinetic limitations, inadequate receptor selectivity, poorly chosen clinical endpoints, or the absence of enabling technologies at the time of initial evaluation